CLARICULE is indicated in the treatment of infections due to susceptible organisms whenever parenteral therapy is required. CLARICULE is an effective and safe treatment for upper and lower respiratory tract infections. For full prescribing information, refer to the professional information approved by the South African Health Products Regulatory Authority.

According to the antibiotic guidelines CLARICULE can be used for:

• The treatment for Hospitalised Patients (Non-ICU) for Community-Acquired Pneumonia as combination therapy for atypical cover as a 500 mg IV 12 hourly dose.
• The treatment for Community-Acquired Pneumonia in ICU Patients, as a 500 mg IV 12 hourly dose, as combination therapy for atypical cover. Treatment for Atypical Pneumonia as monotherapy as a 500 mg PO / IV 12 hourly dose. For full prescribing information refer to the professional information approved by the South African Health Products Regulatory Authority.

General contact information:

• info.mahsa@imperiallogistics.com
• Tel: 011 677 5000

For any quality or safety related queries, please contact Imperial Quality at quality.healthcare@imperiallogistics.com or Imperial Medical at pv@imperiallogistics.com.